Table 1.

The results provided by an MLP(12:24:6:2) in the testing phase.

VFI1	VFI2	VFI3	MD1	MD2	MD3	PSD1	PSD2	PSD3	RNFL1	RNFL2	RNFL3	Progression in clinical observation	Progression with MLP
99	98	100	0.62	− 0.76	0.04	1.82	1.84	1.33	86	85	85	No	No
97	97	99	− 0.65	− 0.72	− 0.36	2.16	2.1	1.58	102	98	98	No	No
97	98	99	− 2.15	− 4.49	− 1.62	1.91	1.65	1.58	73	73	73	No	No
85	97	96	− 7.52	− 1.37	− 3.23	9.75	2.25	2.18	79	78	77	No	Yes
94	93	92	− 3.89	− 3.71	− 3.77	2.65	4.47	3.44	61	54	54	No	No
86	88	89	− 4.89	− 4.82	− 4.12	4.72	5	5.35	69	68	67	No	No
89	96	93	− 4.84	− 4.08	− 5.39	3.5	2.32	2.49	68	67	66	No	No
94	93	90	− 2.86	− 3.76	− 4.58	3.03	4.38	6.58	77	76	75	Yes	Yes
98	98	97	− 0.96	− 1.67	− 0.66	3.75	1.89	3.41	64	61	61	No	No
65	60	39	− 12.46	− 12.12	− 18.42	8.96	9.2	12.52	40	38	36	Yes	Yes
94	91	96	− 2.41	− 2.97	− 2.63	5.02	4.45	2.89	55	55	54	No	No
23	35	34	− 26.11	− 24.21	− 23.79	8.21	10.34	9.71	38	37	37	No	No
100	99	100	0.14	− 1.72	− 0.56	1.21	1.45	1.25	99	96	95	No	No
93	93	97	− 5.76	− 5.01	− 3.23	2.5	2.56	1.93	59	57	52	No	No
78	57	47	− 9.8	− 15.16	− 19.63	9.54	11.89	12.41	55	50	49	Yes	Yes